Pacira BioSciences, Inc. — Director's Dealing 2011

Jun 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2011-06-02

Reporting Person: Brege Laura (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-02	Stock option (right to buy)	$13.98	A	15000	Acquired	2021-06-02	Common Stock (15000)	Direct

Footnotes

F1: Options will vest in 24 equal monthly installments beginning on July 2, 2011.